Secondly, even though our study has demonstrated a correlation between FANCD2 expression and immune activity as well as clinical survival in pan-cancer, we cannot definitively confirm whether FANCD2 directly impacts clinical survival through an immune pathway. Here, FANCD2 is linked to cancer.